Serum GFAP as a biomarker for disease severity in multiple sclerosis
A. Abdelhak, A. Huss, J. Kassubek et al. · Scientific Reports · 2018
Full textCC BY
Pathology and Forensic Medicine
Filters3 filters applied
Status
Year
5 papersQuestions on this topic
Corrected Corrected Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis
Neil H. Riordan, Isabela Morales, Giselle Fernández et al. · Journal of Translational Medicine · 2018
Full textCC BY
Corrected Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms
J. Matthew Mahoney, Jaclyn Taroni, Viktor Martyanov et al. · PLoS Computational Biology · 2015
Full textCC BY
Corrected Mining CK2 in Cancer
Charina E. Ortega, Yoshua Seidner, Isabel Dominguez · PLoS ONE · 2014
Full textCC BY
Corrected Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
Jeppe Romme Christensen, Lars Börnsen, Rikke Ratzer et al. · PLoS ONE · 2013
Full textCC BY